Single-Dose Attenuated Vesiculovax Vaccines Protect Primates Against Ebola Makona Virus

Nature - United Kingdom
doi 10.1038/nature14428
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Evaluation in Nonhuman Primates of Vaccines Against Ebola Virus

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2002English

DNA Vaccines Encoding Proteins From Wild-Type and Attenuated Canine Distemper Virus Protect Equally Well Against Wild-Type Virus Challenge

Archives of Virology
MedicineVirology
2012English

A Perspective on the Development of Plant-Made Vaccines in the Fight Against Ebola Virus

Frontiers in Immunology
AllergyImmunology
2017English

Vector Choice Determines Immunogenicity and Potency of Genetic Vaccines Against Angola Marburg Virus in Nonhuman Primates

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2010English

Transmission of Ebola Virus From Pigs to Non-Human Primates

Scientific Reports
Multidisciplinary
2012English

Differences in the Comparative Stability of Ebola Virus Makona-C05 and Yambuku-Mayinga in Blood

PLoS ONE
Multidisciplinary
2016English

Recently Identified Mutations in the Ebola Virus-Makona Genome Do Not Alter Pathogenicity in Animal Models

Cell Reports
BiochemistryGeneticsMolecular Biology
2018English

Mucosal Vaccines Against Respiratory Syncytial Virus

Current Opinion in Virology
Virology
2014English

Live Attenuated Influenza Virus Vaccines by Computer-Aided Rational Design

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy